The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

A Journey from Fundamental Research to Therapeutic Approach

October 25, 2023
A Journey from Fundamental Research to Therapeutic Approach

Transitioning from one area of research to another is a thrilling journey filled with challenges and opportunities. As a cancer researcher, I have experienced different fields of investigation and the need to constantly adapt to new realities to stay at the forefront of knowledge. In this blog post, I will share my story of transitioning from fundamental research to a therapeutic approach and the valuable lessons I have learned.

My scientific journey began during my undergraduate studies in Biomedical Sciences. With a passion for understanding the complexities of cancer biology, I pursued a master’s degree in molecular Biomedicine. However, during a laboratory rotation, I realized the potential of nanotechnology to revolutionize cancer treatment. Little did I know that this experience would contribute to a significant transition in my research career. Consequently, my master’s thesis focused on developing polymer-based nanosystems capable of efficiently delivering genetic material to T cells for potential T cell-based therapies. To undertake this new path, I had to learn and adapt to the principles of nanotechnology, materials science, and gene delivery systems. It demanded openness to learning, interdisciplinary collaboration, and adopting novel approaches.

One of the challenges I faced was acquiring the necessary knowledge and skills in nanotechnology. I immersed myself in scientific literature, attended workshops, and engaged with experts in the field to expand my knowledge. It was a stimulating experience to step into unknown territory, discovering the possibilities and limitations of nanomedicine.
Adapting to research methodologies and laboratory techniques was another challenge in my journey. I had to familiarize myself with specialized equipment and experimental protocols. It required patience and persistence to assume trial and error.

Transitioning to nanotechnology field also introduced me to a world of collaboration. I recognized my lack in aspects of nanomedicine, and therefore, I actively searched for collaborations with scientists from diverse disciplines, including materials science, immunotherapy, and oncobiology. By harnessing the collective knowledge and skills of experts, we were able to address complex challenges and make significant contributions to our research.

At the EACR 2023 Annual Congress

I also discovered the importance of staying connected within the scientific community. Active participation in conferences, workshops, and scientific societies such as ASPIC, EACR, AACR, and FEBS became crucial to my growth as a researcher. These societies provided opportunities to exchange ideas, learn about innovative research, and build networks with scientists.

Lastly, I recognized the value of effective science communication in driving progress and creating societal impact. I actively engaged in science outreach activities, such as the Pint of Science initiative, to promote scientific literacy by facilitating dialogue and breaking down barriers between researchers and society.

My transition from fundamental research to a therapeutic approach led me to the importance of embracing changes, seeking knowledge outside my comfort zone, collaborating with diverse experts, and effectively communicating science. As cancer research continues to grow, I remain committed to adapting to the different areas of investigation that may emerge to make a significant contribution to the fight against cancer.


About the author:

Inês Pinto is an enthusiastic cancer researcher at the Center for Neuroscience and Cell Biology at the University of Coimbra. With a master’s degree in molecular Biomedicine and a bachelor’s degree in biomedical sciences, she has dedicated her career to advancing cancer nanomedicine, targeted delivery nanoplatforms, biomaterials, immunotherapy, and oncobiology. Inês is actively involved in scientific societies, science outreach activities, and sustainable research practices, aiming to develop novel therapeutic strategies against cancer.


About this article

This is one of our shortlisted entries for the 2023 EACR Science Communication Prize on the topic of Science in Motion: Navigating Transitions. Choosing a winner was incredibly difficult and we’re delighted to be able to share our amazing shortlist.
Tags: EACR MembersEACR Science Communication Prize 2023The Cancer Researcher-EACR Science Communication Prize

Related Posts

Irene Casanova Salas two years into her EACR-AstraZeneca Postdoctoral Fellowship

Irene Casanova Salas two years into her EACR-AstraZeneca Postdoctoral Fellowship

June 4, 2026

Irene Casanova Salas was the 2024 recipient of an EACR-AstraZeneca Postdoctoral Fellowship, funding that is awarded for a period of up to three years to support...

How the EACR Congress inspired translational innovation and the launch of a spin-out company

How the EACR Congress inspired translational innovation and the launch of a spin-out company

May 14, 2026

EACR member Munitta Muthana provides some insight into her team’s experience at EACR 2025 in Lisbon, and how it catalysed the momentum and vision for their...

“This technique is highly complex and would not have been possible to perform in my lab”: María Martínez Fernández’s EACR Travel Fellowship

“This technique is highly complex and would not have been possible to perform in my lab”: María Martínez Fernández’s EACR Travel Fellowship

May 12, 2026

María Martínez Fernández is a PhD student at the Institute of Neuroscience of Castilla y León, Salamanca, Spain who received an EACR Travel Fellowship to visit...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

Irene Casanova Salas two years into her EACR-AstraZeneca Postdoctoral Fellowship
Career

Irene Casanova Salas two years into her EACR-AstraZeneca Postdoctoral Fellowship

June 4, 2026
VIDEO | Bridging Spatial Proteomics and Transcriptomics: Multimodal Integration for Deeper Insight and Clinical Translation
News

VIDEO | Bridging Spatial Proteomics and Transcriptomics: Multimodal Integration for Deeper Insight and Clinical Translation

June 3, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR